Cai, W., Cai, B., Zhou, J., Chen, Y., Zhang, J., Huang, Y., . . . Huang, J. (2019). Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: A retrospective study. Cancer Commun (Lond).

Cai, Wen, Biao Cai, Juan Zhou, Yonghui Chen, Jin Zhang, Yiran Huang, Wei Xue, και Jiwei Huang. "Comparison of Efficacy and Safety Among Axitinib, Sunitinib, and Sorafenib As Neoadjuvant Therapy for Renal Cell Carcinoma: A Retrospective Study." Cancer Commun (Lond) 2019.

Cai, Wen, et al. "Comparison of Efficacy and Safety Among Axitinib, Sunitinib, and Sorafenib As Neoadjuvant Therapy for Renal Cell Carcinoma: A Retrospective Study." Cancer Commun (Lond) 2019.